Literature DB >> 17476082

Predictors of long term neurological outcome in bacterial meningitis.

Pratibha Singhi1, Arun Bansal, P Geeta, Sunit Singhi.   

Abstract

OBJECTIVE: To study the long-term neurological and developmental outcome and the clinical and laboratory predictors of sequelae in children with acute bacterial meningitis (ABM).
METHODS: Detailed clinical and demographic data was retrieved from the medical records of study children. Subsequently they were followed up for a minimum of 12 months after discharge for development, neurological and hearing assessment. All sequelae were identified and divided into minor or major. For analysis data was divided into 2 groups those with sequelae and without sequelae at follow-up. Statistical analysis was done using SPSS version 10.00 and Epi Info version 2000.
RESULTS: 61 boys and 19 girls, a mean age of 31.4 +/= 41.9 months at the time of ABM, were included in the study. Of these 62.5% children were infants. Mean age at follow-up was 58.6 +/= 47.2 months. Sequelae were observed in 32 (40%) children (8 (10%) minor and 24 (30%) major). Mean social quotient at follow-up was 92.8 +/= 32.6. Developmentally 22 (37.9%) children were normal and 20 (34.5%) had global delay. Seizures (P=0.015), cranial nerve palsy (P=0.0065), abnormal deep tendon reflexes (P=0.002), Glasgow coma scale score (GCS) < 8 (P = 0.044) at admission, a CSF culture positive for bacteria and abnormal findings on ultrasonography or computed tomography of head at admission had significant association with sequelae at follow-up. All children (7/7) who had infarct on CT scan (P=0.001) and 12 (80%) of 15 patients who had hydrocephalus (OR - 9.0, 95% CI - 2.03-45.6, P=0.001) diagnosed on CT scan developed severe sequelae. On multiple regressions GCS score <8, presence of cranial nerve palsy and abnormal deep tendon reflexes were independent predictors of sequelae.
CONCLUSION: Neurological and audiological sequelae and global developmental delay may be seen in about one third of survivors of bacterial meningitis. GCS score <8, presence of infarct or cranial nerve palsy, or hydrocephalous on CT/ ultrasound at admission may help in identification of children most likely to need long term follow up and rehabilitation.

Entities:  

Mesh:

Year:  2007        PMID: 17476082     DOI: 10.1007/s12098-007-0062-6

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   5.319


  32 in total

1.  A clinical study of chronic morbidity in children following pyogenic meningitis.

Authors:  Ciji N George; S Letha; S Sushama Bai
Journal:  Indian Pediatr       Date:  2002-07       Impact factor: 1.411

2.  Cognitive and executive function 12 years after childhood bacterial meningitis: effect of acute neurologic complications and age of onset.

Authors:  Vicki Anderson; Peter Anderson; Keith Grimwood; Terry Nolan
Journal:  J Pediatr Psychol       Date:  2004-03

3.  Survival and sequelae of meningococcal meningitis in Ghana.

Authors:  A Hodgson; T Smith; S Gagneux; I Akumah; M Adjuik; G Pluschke; F Binka; B Genton
Journal:  Int J Epidemiol       Date:  2001-12       Impact factor: 7.196

4.  Sequelae of acute bacterial meningitis in children treated for seven days.

Authors:  T Jadavji; W D Biggar; R Gold; C G Prober
Journal:  Pediatrics       Date:  1986-07       Impact factor: 7.124

5.  Report of the Task Force on Diagnosis and Management of Meningitis.

Authors:  J O Klein; R D Feigin; G H McCracken
Journal:  Pediatrics       Date:  1986-11       Impact factor: 7.124

6.  Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group.

Authors:  H Peltola; M Anttila; O V Renkonen
Journal:  Lancet       Date:  1989-06-10       Impact factor: 79.321

7.  Long-term follow-up of children with bacterial meningitis with emphasis on behavioural characteristics.

Authors:  Stefan Berg; Birger Trollfors; Svante Hugosson; Elisabeth Fernell; Elisabeth Svensson
Journal:  Eur J Pediatr       Date:  2002-04-25       Impact factor: 3.183

8.  Long term sequelae of childhood acute bacterial meningitis in a developing country. A study from the Sudan.

Authors:  M A Salih; O H Khaleefa; M Bushara; Z B Taha; Z A Musa; I Kamil; Y Hofvander; P Olcén
Journal:  Scand J Infect Dis       Date:  1991

9.  Adverse outcomes of bacterial meningitis in school-age survivors.

Authors:  K Grimwood; V A Anderson; L Bond; C Catroppa; R L Hore; E H Keir; T Nolan; D M Roberton
Journal:  Pediatrics       Date:  1995-05       Impact factor: 7.124

10.  Sensorineural hearing loss following acute bacterial meningitis in non-neonates.

Authors:  B Cherian; T Singh; B Chacko; A Abraham
Journal:  Indian J Pediatr       Date:  2002-11       Impact factor: 1.967

View more
  20 in total

1.  Outcome of meningitis among children less than 2-y-old in Haryana.

Authors:  Sunit C Singhi; Madhu Gupta; Dinesh Kumar; Rajesh Kumar
Journal:  Indian J Pediatr       Date:  2012-04-14       Impact factor: 1.967

2.  Use of quantitative broad-based polymerase chain reaction for detection and identification of common bacterial pathogens in cerebrospinal fluid.

Authors:  Richard Rothman; Padmini Ramachandran; Samuel Yang; Andrew Hardick; Helen Won; Aleksandar Kecojevic; Celeste Quianzon; Yu-Hsiang Hsieh; Charlotte Gaydos
Journal:  Acad Emerg Med       Date:  2010-07       Impact factor: 3.451

3.  Pentavalent vaccine: a major breakthrough in India's Universal Immunization Program.

Authors:  Mohan Bairwa; Manju Pilania; Meena Rajput; Pardeep Khanna; Neelam Kumar; Mukesh Nagar; Sumit Chawla
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

4.  Acute meningoencephalitis in hospitalised children in southern Bangladesh.

Authors:  Choudhury Habibur Rasul; Foiz Muhammad; M Jahangir Hossain; Khayer Uddin Ahmed; Mahmudur Rahman
Journal:  Malays J Med Sci       Date:  2012-04

5.  Rapid diagnosis and simultaneous identification of tuberculous and bacterial meningitis by a newly developed duplex polymerase chain reaction.

Authors:  Khushboo J Nagdev; Sharda P Bhagchandani; Shradha S Bhullar; Rajkumar C Kapgate; Rajpal S Kashyap; Nitin H Chandak; Hatim F Daginawala; Hemant J Purohit; Girdhar M Taori
Journal:  Indian J Microbiol       Date:  2015-02-03       Impact factor: 2.461

6.  Factors influencing neurological outcome of children with bacterial meningitis at the emergency department.

Authors:  Fatiha Bargui; Irene D'Agostino; Patricia Mariani-Kurkdjian; Corinne Alberti; Catherine Doit; Nathalie Bellier; Laurence Morin; Giuliano Galli Gibertini; Assia Smail; Anna Zanin; Mathie Lorrot; Stéphane Dauger; Mathieu Neve; Albert Faye; Priscilla Armoogum; Antoine Bourrillon; Edouard Bingen; Jean-Christophe Mercier; Stéphane Bonacorsi; Lise E Nigrovic; Luigi Titomanlio
Journal:  Eur J Pediatr       Date:  2012-04-19       Impact factor: 3.183

7.  Dementia and capsular genu ischemia in patients with severe bacterial meningitis.

Authors:  Makoto Naito; Ken Johkura; Takayuki Momoo; Tamaki Nomiya; Yosuke Kudo; Yoshiyuki Kuroiwa
Journal:  Neurol Sci       Date:  2009-10-17       Impact factor: 3.307

Review 8.  Predicting sequelae and death after bacterial meningitis in childhood: a systematic review of prognostic studies.

Authors:  Rogier C J de Jonge; A Marceline van Furth; Merel Wassenaar; Reinoud J B J Gemke; Caroline B Terwee
Journal:  BMC Infect Dis       Date:  2010-08-05       Impact factor: 3.090

9.  Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India.

Authors:  Andrew D Clark; Ulla K Griffiths; Syed Shahid Abbas; Krishna D Rao; Lois Privor-Dumm; Rana Hajjeh; Hope Johnson; Colin Sanderson; Mathuram Santosham
Journal:  J Pediatr       Date:  2013-07       Impact factor: 4.406

10.  Risk factors for death and severe sequelae in Malawian children with bacterial meningitis, 1997-2010.

Authors:  David W McCormick; Mark L Wilson; Limangeni Mankhambo; Ajib Phiri; Yamikani Chimalizeni; Kondwani Kawaza; Brigitte Denis; Enitan D Carrol; Elizabeth M Molyneux
Journal:  Pediatr Infect Dis J       Date:  2013-02       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.